News
BRSYF
10.62
NaN%
--
Lifeward Brings $22M Revenue, Reimbursed Robotics and an AI Pipeline to an $11.5M Market Cap (NASDAQ: LFWD)
TipRanks · 1d ago
Brainsway reports Q3 EPS 5c, consensus 9c
TipRanks · 11/10 16:38
Brainsway announces strategic collaboration with Mindful Health Solutions
TipRanks · 11/02 12:40
Brainsway: Buy Rating Reaffirmed on Strategic Momentum and Reimbursement Expansion; 12‑Month Price Target Maintained at $19
TipRanks · 10/19 16:06
Brainsway reports rise in Swift Accelerated Deep TMS protocol coverage
TipRanks · 10/13 11:35
Brainsway publishes results from pilot study
TipRanks · 09/08 11:45
Brainsway price target raised to $19 from $17 at H.C. Wainwright
TipRanks · 08/31 10:10
Brainsway reports Q2 EPS 7c, consensus 7c
TipRanks · 08/17 09:48
Brainsway raises FY26 revenue view to $68M-$70M from $66M-$68M
TipRanks · 08/17 09:48
BrainsWay makes $3M minority investment in Radial Health
Seeking Alpha · 07/20 12:10
Brainsway initiated with a Buy at BTIG
TipRanks · 07/20 10:00
BrainsWay: Buy Rating Reaffirmed with Unchanged $17 Price Target on Strategic Sound Minds Investment and Deep TMS Growth Drivers
TipRanks · 07/17 10:25
Analyst Reiterates Buy on BrainsWay, Citing Strong Deep TMS Data and SWIFT Coverage Expansion; 12-Month Price Target Maintained at $17
TipRanks · 07/02 10:35
Brainsway presents new Deep Transcranial Magnetic Stimulation data
TipRanks · 06/29 11:46
Analyst Reiterates Buy on Brainsway, Maintains $17 Price Target Amid Expanding Reimbursement and Strategic Investments
TipRanks · 06/22 14:35
Brainsway price target raised to $17 from $15 at H.C. Wainwright
TipRanks · 05/26 10:16
Brainsway announces $1.5M investment in APS Innovations
TipRanks · 05/18 11:48
Brainsway reports Q1 EPS 6c, consensus 5c
TipRanks · 05/13 12:02
Brainsway backs FY26 revenue view $66M-$68M, consensus $66.44M
TipRanks · 05/13 12:01
Brainsway completes revenue-based milestone investment into Axis Integrated
TipRanks · 03/19 12:00
More
Webull provides a variety of real-time BRSYF stock news. You can receive the latest news about Brainsway through multiple platforms. This information may help you make smarter investment decisions.
About BRSYF
Brainsway Ltd is an Israel-based company engaged in the development and marketing of medical devices for the treatment of various neurological and psychopathological disorders. The Company primarily offers Transcranial Magnetic Stimulation (TMS) system, a medical device that enables direct non-invasive activation of deep brain structures. Its TMS system uses magnetic pulses to stimulate neurons and consequently modulates the physiological activity of the brain. TMS system is used in various clinical applications including: major depressive disorders, obsessive-compulsive disorder, smoking addiction and others various psychiatric, neurological, and addiction disorders.